From: Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
Category | End points | Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |||
Clinical predictors | PFS | NCCN-IPI | 1.331 | 1.145–1.548 |  < 0.001 | 1.215 | 1.021–1.445 | 0.028 |
 |  | β2-MG | 2.668 | 1.606–4.433 |  < 0.001 | 1.904 | 1.060–3.421 | 0.031 |
 | OS | NCCN-IPI | 1.419 | 1.174–1.715 |  < 0.001 | 1.294 | 1.041–1.607 | 0.020 |
 |  | β2-MG | 3.015 | 1.589–5.719 |  < 0.001 | 1.933 | 0.927–4.030 | 0.079 |
Metabolic parameters | PFS | SUVmax | 1.352 | 0.814–2.247 | 0.244 | – | – | – |
 |  | SDmax | 5.592 | 2.652–11.790 |  < 0.001 | 4.758 | 2.236–10.120 |  < 0.001 |
 |  | TMTV | 2.816 | 1.654–4.796 |  < 0.001 | 2.186 | 1.275–3.750 | 0.004 |
 | OS | SUVmax | 1.664 | 0.849–3.262 | 0.138 | – | – | – |
 |  | SDmax | 4.499 | 2.126–9.517 |  < 0.001 | 3.939 | 1.832–8.469 |  < 0.001 |
 |  | TMTV | 2.441 | 1.209–4.932 | 0.013 | 1.797 | 0.874–3.697 | 0.111 |